The combination of AU-011 with anti-LAG-3 and PD-L1 induced the strongest tumor growth inhibition and significantly enhanced survival, resulting in CR in approximately 75% of animals at 60 days post-inoculation (Fig. 6f). Here, LAG3 is linked to neoplasm.